The Russian Direct Investment Fund (RDIF) has signed an agreement with the Swiss-based pharmaceutical company Adienne to produce the Russian vaccine against COVID-19 Sputnik V in Italy, the Italian-Russian Chamber of Commerce said in a statement.
The announcement, issued Monday, which was a holiday in Russia, added that the move paves the way for the creation of the first Sputnik V production unit in Europe, while Italian production is scheduled to begin in June.
The Italian-Russian Chamber of Commerce says it hopes 10 million doses of Sputnik V could be produced in Italy by the end of the year.
Source: politis.com.cy
